Asia Pacific
Pregnancy & Ovulation Testing Market Research Report: By Type (hCG
Detection, Ovulation Testing), by Mode of Purchase (OTC Testing, Prescription
Testing), End-User (Hospitals & Clinics, Fertility Centers, Others) –
Global Forecast Till 2023
Regional Outlook
Region-wise, the Pregnancy and Ovulation Testing Market includes Japan, China, India, Republic of Korea,
Australia, and Rest of Asia Pacific. Japan is anticipated to experience a
phenomenal CAGR of 6.26% during the forecast period owing to sophisticated
healthcare infrastructure and high capita per income of citizens. Rising demand
for self-contained kits is expected to bolster market demand in the coming
years. China and India markets can enjoy a tremendous demand over the forecast
period due to high awareness levels of testing kits and numerous manufacturers
launching new products annually in the region.
Competitive Dashboard
The market is highly fragmented
and various players, at an international as well as regional levels, are
imposing themselves as market influencers. Some of the key players profiled in
the report include Piramal Enterprises Ltd., Mankind Pharma Ltd., Fairhaven
Health, LLC, Cadila Healthcare Limited, Quidel Corporation, Geratherm Medical
AG, TaiDoc Technology & Corporation, Church & Dwight Co., Inc., Gregory
Pharmaceutical Holdings, Inc., and Proctor & Gamble.
The Pregnancy and Ovulation
Testing Market is touted to touch USD 298.68 billion mark at a staggering CAGR
of 6.1% during the forecast period (2018-2023), Market Research Future (MRFR)
reports. Pregnancy and ovulation testing kits are designed to assist women in
conceiving children. The former can predict accurate results by detecting the
presence of human chorionic gonadotropin (hCG) in urine, while the latter
assists women by witnessing a surge in luteinizing hormone (LH) levels.
Advances in home testing kits
coupled with the high smartphone penetration rate have digitized test results.
For instance, the FIRST RESPONSE Pregnancy PRO Digital Test & App Access by
Church & Dwight Co., an American manufacturer, offers consumers a
convenient method to test fertility. The Asia Pacific (APAC) market is driven
by availability of ovulation monitors on ecommerce websites, inclination of
consumers to shop online, declining fertility rates, and promotional campaigns
by various manufacturers to create awareness among consumers.
Access Report @ https://www.marketresearchfuture.com/reports/asia-pacific-pregnancy-ovulation-testing-market-6198
Segmental Analysis
The Asia Pacific market for
Pregnancy Test Kit Market can be segmented based on type, mode of purchase,
end-user.
By type, the market has been
segmented into pregnancy testing (hCG detection) and ovulation testing.
The pregnancy testing segment is likely to capture a larger market share
by 2023 thanks to continuous advances in testing kits and demand for
self-contained test kits. Rise in gynecological disorders and demand from women
suffering from polycystic ovary syndrome (PCOS) are factors likely to fuel
segment growth.
By mode of purchase, the market
is segmented into prescription testing and non-prescription
testing/over-the-counter (OTC) testing. The non-prescription/OTC segment is
likely to be the preferred mode of purchase owing to easy access to pregnancy
and ovulation test kits in pharmacies and rise in adolescent pregnancy rates.
End-users in the APAC pregnancy
and ovulation testing market include fertility centers, hospitals and clinics,
and others. The hospitals and clinics segment is anticipated to be the biggest
market end-user owing to huge patient pools of India and China. Increasing
preference of women to undergo pregnancy tests at hospitals is expected to
bolster segment demand during the forecast period.
No comments:
Post a Comment